Literature DB >> 17543592

HPLC method for the determination of carboplatin and paclitaxel with cremophorEL in an amphiphilic polymer matrix.

Anupama Mittal1, Deepak Chitkara, Neeraj Kumar.   

Abstract

Simple and rapid reversed phase HPLC methods for individual as well as simultaneous analysis of paclitaxel and carboplatin with cremophorEL (CrEL) in an amphiphilic polymer matrix were developed. Different analytical performance parameters such as linearity, accuracy, precision, specificity, limit of detection (LOD) and limit of quantification (LOQ) were determined according to ICH guidelines. All the analytical methods were developed by reverse phase HPLC on C-18 column with a mobile phase comprising of water-acetonitrile run on isocratic mode for the analysis of carboplatin and gradient mode for individual analysis of paclitaxel and for simultaneous analysis of the two drugs at a flow rate of 1 ml/min at 227 nm. The proposed methods for independent analysis of the drugs elute out carboplatin in 4.3 min and paclitaxel in 10.5 min while in simultaneous analysis carboplatin shows R(t) at 4 min and paclitaxel at 18 min with a continuous run for 17 more minutes to elute out CrEL. These methods were found to be specific as none of the components of the media, i.e. polymer, CrEL and buffer interfered with the drug peaks. The linearity of the calibration curves for each analyte in the desired concentration range was found to be good (r(2)>0.9995). The methods were accurate and precise with recoveries ranging from 98 to 101% for each drug and relative standard deviation (%RSD) <2%. Peaks corresponding to each of the drug showed positive value for the minimum peak purity index over the entire range of integrated chromatographic peak thus indicating the purity of the peaks. Stability analysis of the two drugs revealed that the drugs remain stable during the period of study.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17543592     DOI: 10.1016/j.jchromb.2007.05.005

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  5 in total

1.  Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio.

Authors:  Tianzhi Yang; Paige Martin; Brittany Fogarty; Alison Brown; Kayla Schurman; Roger Phipps; Viravuth P Yin; Paul Lockman; Shuhua Bai
Journal:  Pharm Res       Date:  2015-01-22       Impact factor: 4.200

2.  Carboplatin-Complexed and cRGD-Conjugated Unimolecular Nanoparticles for Targeted Ovarian Cancer Therapy.

Authors:  Yuyuan Wang; Liwei Wang; Guojun Chen; Shaoqin Gong
Journal:  Macromol Biosci       Date:  2016-12-01       Impact factor: 4.979

3.  Encapsulation in nanoparticles improves anti-cancer efficacy of carboplatin.

Authors:  Tanmoy Sadhukha; Swayam Prabha
Journal:  AAPS PharmSciTech       Date:  2014-05-16       Impact factor: 3.246

4.  Rapid and sensitive liquid chromatographic method for determination of Paclitaxel from parenteral formulation and nanoparticles.

Authors:  S Kollipara; G Bende; R N Saha
Journal:  Indian J Pharm Sci       Date:  2010-07       Impact factor: 0.975

5.  Extraction and RP-HPLC determination of taxol in rat plasma, cell culture and quality control samples.

Authors:  Rakesh Kumar Tekade; Antony D'Emanuele; Abdelbary Elhissi; Ashish Agrawal; Anurekha Jain; Basel Tawfiq Arafat; Narendra Kumar Jain
Journal:  J Biomed Res       Date:  2013-08-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.